Company Number: 14850085

Analysis Date: 2025-07-29 17:50 UTC

Certainly, let's conduct a comprehensive financial health assessment for GG-319-603 LIMITED based on the available data.

---

1. Financial Health Score: D

Explanation:
The company shows initial signs of financial distress, primarily reflected in negative net current assets and shareholders' funds. This indicates that liabilities slightly exceed assets, which is a warning "symptom" of potential liquidity and solvency issues. Given the company is newly incorporated (2023) and has not yet generated profits or built equity, this grade reflects early-stage caution rather than chronic illness.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Current Assets	50,103	Cash and receivables available to cover short-term obligations.
Current Liabilities	51,701	Debts due within one year. Slightly higher than current assets.
Net Current Assets (Working Capital)	-1,598	Negative working capital indicates short-term liquidity strain.
Net Assets (Total Equity)	-1,598	Company's book value is negative; liabilities exceed assets.
Called up Share Capital	100	Very low equity funding, typical for a start-up phase.
Profit and Loss Reserve	-1,698	Accumulated losses or initial expenses exceeding capital.
Employees	NIL	No staff employed yet; low operating overheads.

Interpretation of Vital Signs:
The "vital signs" show a fragile financial state. Negative net current assets imply the company may struggle to meet short-term debts as they fall due without additional financing or revenue inflow. Negative net assets (shareholders' funds) depict that the business is technically insolvent on a balance sheet basis, though this is not unusual for a very young company still in the investment or setup phase.

---

3. Diagnosis

The company is in its infancy, having incorporated in May 2023 and reporting its first financial year end as December 2023. The financial statements reveal the company is in a "startup condition" with initial expenses or debts slightly exceeding available assets. The absence of employees suggests minimal operating costs but also no operational revenue generation yet.

The "symptoms" of distress—negative working capital and shareholders' funds—are likely due to start-up costs, perhaps financed by trade creditors or other short-term liabilities. The company is not in immediate "acute distress," but without incoming cash flow or capital injection, it may face liquidity pressure.

The director’s declaration indicates compliance with small companies' accounting standards, but the opting out of delivering the profit and loss account limits insight into revenue or expenses trends.

---

4. Recommendations

• Strengthen Liquidity:
  Seek additional capital injections or loans to improve working capital and offset negative net current assets. This is akin to administering IV fluids to a patient showing early dehydration symptoms.

• Revenue Generation:
  Accelerate commercial activity to generate cash inflows. Early sales or contracts will improve cash flow and shift the company from "pre-revenue" to operational health.

• Cost Management:
  Monitor and control overhead expenses closely to prevent further erosion of equity.

• Financial Monitoring:
  Implement monthly cash flow forecasts to detect liquidity shortages early and manage creditor payments prudently.

• Stakeholder Communication:
  Keep shareholders and creditors informed of the company’s progress and plans to ensure continued support.

• Prepare for Next Filing:
  Given the company’s early stage, ensure timely filing of accounts and confirmation statements to avoid penalties and maintain good standing.

---